Medical School

  • Harvard Medical School , 1969 , Boston , MA


Internal Medicine
  • Massachusetts General Hospital , 1970 , Boston , MA


  • Massachusetts General Hospital , 1971 , Boston , MA


  • Massachusetts General Hospital , 1973 , Boston , MA


Infectious Diseases
  • Massachusetts General Hospital , 1975 , Boston , MA


  • American Board of Internal Medicine
  • American Board of Internal Medicine, Infectious Diseases


Publications powered by Harvard Catalyst Profiles

  1. Institutional quality and patient safety programs: An overview for the healthcare epidemiologist. Infect Control Hosp Epidemiol. 2021 Jan; 42(1):6-17. View abstract
  2. A Collaborative Multicenter QI Initiative to Improve Antibiotic Stewardship in Newborns. Pediatrics. 2019 12; 144(6). View abstract
  3. The impact of measurement changes on evaluating hospital performance: The case of catheter-associated urinary tract infections. Infect Control Hosp Epidemiol. 2019 11; 40(11):1269-1271. View abstract
  4. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650. View abstract
  5. Association Between Value-Based Incentive Programs and Catheter-Associated Urinary Tract Infection Rates in the Critical Care Setting. JAMA. 2019 02 05; 321(5):509-511. View abstract
  6. Effectiveness of a multistate quality improvement campaign in reducing risk of surgical site infections following hip and knee arthroplasty. BMJ Qual Saf. 2019 05; 28(5):374-381. View abstract
  7. Practical recommendations for the evaluation of improvement initiatives. Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):29-36. View abstract
  8. Salzburg Global Seminar Session 565-'Better Health Care: how do we learn about improvement?' Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):1-4. View abstract
  9. A framework for learning about improvement: embedded implementation and evaluation design to optimize learning. Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):10-14. View abstract
  10. The Impact of the Medicaid Healthcare-Associated Condition Program on Mediastinitis Following Coronary Artery Bypass Graft. Infect Control Hosp Epidemiol. 2018 06; 39(6):694-700. View abstract
  11. Highly Adoptable Improvement: A Practical Model and Toolkit to Address Adoptability and Sustainability of Quality Improvement Initiatives. Jt Comm J Qual Patient Saf. 2018 03; 44(3):155-163. View abstract
  12. Are quality improvement collaboratives effective? A systematic review. BMJ Qual Saf. 2018 03; 27(3):226-240. View abstract
  13. A Way Forward for Bipartisan Health Reform? Democrat and Republican State Legislator Priorities for the Goals of Health Policy. Am J Public Health. 2017 10; 107(10):1601-1603. View abstract
  14. How to attribute causality in quality improvement: lessons from epidemiology. BMJ Qual Saf. 2017 11; 26(11):933-937. View abstract
  15. Randomized Trial of Reducing Ambulatory Malpractice and Safety Risk: Results of the Massachusetts PROMISES Project. Med Care. 2017 08; 55(8):797-805. View abstract
  16. Erratum to: Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci. 2017 05 10; 12(1):59. View abstract
  17. Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci. 2017 04 17; 12(1):51. View abstract
  18. Contribution of real-time PCR to Plasmodium species identification and to clinical decisions: a nationwide study in a non-endemic setting. Eur J Clin Microbiol Infect Dis. 2017 Apr; 36(4):671-675. View abstract
  19. A Pediatric Approach to Ventilator-Associated Events Surveillance. Infect Control Hosp Epidemiol. 2017 03; 38(3):327-333. View abstract
  20. Claims-Based Diagnostic Patterns of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy. Vector Borne Zoonotic Dis. 2017 02; 17(2):116-122. View abstract
  21. Measuring Hospital-Wide Mortality-Pitfalls and Potential. J Healthc Qual. 2016 May-Jun; 38(3):187-94. View abstract
  22. Parent and Teen Engagement in Pediatric Health Services Research Training. Acad Pediatr. 2016 07; 16(5):496-498. View abstract
  23. The evolution of healthcare quality measurement in the United States. J Intern Med. 2016 Feb; 279(2):154-9. View abstract
  24. Using Nation-Wide Health Insurance Claims Data to Augment Lyme Disease Surveillance. Vector Borne Zoonotic Dis. 2015 Oct; 15(10):591-6. View abstract
  25. Incidence and Patterns of Extended-Course Antibiotic Therapy in Patients Evaluated for Lyme Disease. Clin Infect Dis. 2015 Nov 15; 61(10):1536-42. View abstract
  26. Choosing Wisely in Newborn Medicine: Five Opportunities to Increase Value. Pediatrics. 2015 Aug; 136(2):e482-9. View abstract
  27. Impact of the Centers for Medicare and Medicaid Services Hospital-Acquired Conditions Policy on Billing Rates for 2 Targeted Healthcare-Associated Infections. Infect Control Hosp Epidemiol. 2015 Aug; 36(8):871-7. View abstract
  28. Staphylococcus epidermidis Bacteremia Induces Brain Injury in Neonatal Mice via Toll-like Receptor 2-Dependent and -Independent Pathways. J Infect Dis. 2015 Nov 01; 212(9):1480-90. View abstract
  29. Teamwork methods for accountable care: relational coordination and TeamSTEPPS®. Health Care Manage Rev. 2015 Apr-Jun; 40(2):116-25. View abstract
  30. Impact of Medicare's Hospital-Acquired Condition policy on infections in safety net and non-safety net hospitals. Infect Control Hosp Epidemiol. 2015 Jun; 36(6):649-55. View abstract
  31. Response to: 'Working smarter, not harder' by Professor Iedema. BMJ Qual Saf. 2015 Apr; 24(4):289-90. View abstract
  32. Evaluating ambulatory practice safety: the PROMISES project administrators and practice staff surveys. Med Care. 2015 Feb; 53(2):141-52. View abstract
  33. A 'work smarter, not harder' approach to improving healthcare quality. BMJ Qual Saf. 2015 Feb; 24(2):100-2. View abstract
  34. Health care-associated infections among critically ill children in the US, 2007-2012. Pediatrics. 2014 Oct; 134(4):705-12. View abstract
  35. Coping with college and inflammatory bowel disease: implications for clinical guidance and support. Inflamm Bowel Dis. 2014 Sep; 20(9):1618-27. View abstract
  36. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2:S21-31. View abstract
  37. Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2:S10-4. View abstract
  38. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014 Aug; 35(8):967-77. View abstract
  39. A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates. Am J Infect Control. 2014 Aug; 42(8):820-8. View abstract
  40. Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol. 2014 Jul; 35(7):797-801. View abstract
  41. Did a quality improvement collaborative make stroke care better? A cluster randomized trial. Implement Sci. 2014 Apr 01; 9(1):40. View abstract
  42. Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitals. Infect Control Hosp Epidemiol. 2014 Feb; 35(2):144-51. View abstract
  43. Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res. 2014 May; 472(5):1619-35. View abstract
  44. Recommendations for evaluation of health care improvement initiatives. Acad Pediatr. 2013 Nov-Dec; 13(6 Suppl):S23-30. View abstract
  45. Hospital readmission and parent perceptions of their child's hospital discharge. Int J Qual Health Care. 2013 Oct; 25(5):573-81. View abstract
  46. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):444-50. View abstract
  47. Rethinking infection prevention research. Lancet. 2013 Mar 30; 381(9872):1078-9. View abstract
  48. Preventing lethal hospital outbreaks of antibiotic-resistant bacteria. N Engl J Med. 2012 Dec 06; 367(23):2168-70. View abstract
  49. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med. 2012 Oct 11; 367(15):1428-37. View abstract
  50. A neonatal model of intravenous Staphylococcus epidermidis infection in mice <24 h old enables characterization of early innate immune responses. PLoS One. 2012; 7(9):e43897. View abstract
  51. Deciphering harm measurement. JAMA. 2012 May 23; 307(20):2155-6. View abstract
  52. Perceived impact of the Medicare policy to adjust payment for health care-associated infections. Am J Infect Control. 2012 May; 40(4):314-9. View abstract
  53. Evaluation of organizational culture among different levels of healthcare staff participating in the Institute for Healthcare Improvement's 100,000 Lives Campaign. Infect Control Hosp Epidemiol. 2012 Feb; 33(2):135-43. View abstract
  54. Impact of the ventilator bundle on ventilator-associated pneumonia in intensive care unit. Int J Qual Health Care. 2011 Oct; 23(5):538-44. View abstract
  55. Health information management and perceptions of the quality of care for children with tracheotomy: a qualitative study. BMC Health Serv Res. 2011 May 23; 11:117. View abstract
  56. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011 Apr 14; 364(15):1407-18. View abstract
  57. Society's failure to protect a precious resource: antibiotics. Lancet. 2011 Jul 23; 378(9788):369-71. View abstract
  58. Ten tips for incorporating scientific quality improvement into everyday work. BMJ Qual Saf. 2011 Apr; 20 Suppl 1:i69-72. View abstract
  59. Meaningful disparities reduction through research and translation programs. JAMA. 2011 Jan 26; 305(4):404-5. View abstract
  60. The promise of comparative effectiveness research. JAMA. 2011 Jan 26; 305(4):400-1. View abstract
  61. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One. 2011 Jan 18; 6(1):e15452. View abstract
  62. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010 Nov 25; 363(22):2124-34. View abstract
  63. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 2010 Sep; 120(9):3220-33. View abstract
  64. Performance characteristics of a methodology to quantify adverse events over time in hospitalized patients. Health Serv Res. 2011 Apr; 46(2):654-78. View abstract
  65. Medication errors in paediatric outpatients. Qual Saf Health Care. 2010 Dec; 19(6):e30. View abstract
  66. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ. 2010 Jul 21; 341:c3359. View abstract
  67. Patient characteristics associated with in-hospital mortality in children following tracheotomy. Arch Dis Child. 2010 Sep; 95(9):703-10. View abstract
  68. Use of population health data to refine diagnostic decision-making for pertussis. J Am Med Inform Assoc. 2010 Jan-Feb; 17(1):85-90. View abstract
  69. Patient safety attitudes of paediatric trainee physicians. Qual Saf Health Care. 2009 Dec; 18(6):462-6. View abstract
  70. Is there a relationship between high-quality performance in major teaching hospitals and residents' knowledge of quality and patient safety? Acad Med. 2009 Nov; 84(11):1510-5. View abstract
  71. Agitation during procedural sedation and analgesia in children. Clin Pediatr (Phila). 2010 Jan; 49(1):35-42. View abstract
  72. A matter of time. JAMA. 2009 Aug 26; 302(8):894-5. View abstract
  73. Predictors of clinical outcomes and hospital resource use of children after tracheotomy. Pediatrics. 2009 Aug; 124(2):563-72. View abstract
  74. Parent-driven technology for decision support in pediatric emergency care. Jt Comm J Qual Patient Saf. 2009 Jun; 35(6):307-15. View abstract
  75. Health care-associated infection reporting: the need for ongoing reliability and validity assessment. Am J Infect Control. 2009 Oct; 37(8):615-8. View abstract
  76. Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines. Clin Infect Dis. 2009 Jan 01; 48(1):13-21. View abstract
  77. Controlled evaluation of Bactec Peds Plus/F and Bactec lytic/10 anaerobic/F media for isolation of Salmonella enterica serovars typhi and paratyphi A from blood. J Clin Microbiol. 2009 Jan; 47(1):245-6. View abstract
  78. The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care. 2008 Oct; 17 Suppl 1:i13-32. View abstract
  79. Impact of a patient-centered technology on medication errors during pediatric emergency care. Ambul Pediatr. 2008 Sep-Oct; 8(5):329-35. View abstract
  80. Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients. Am J Health Syst Pharm. 2008 Jul 01; 65(13):1254-60. View abstract
  81. Reducing absenteeism from gastrointestinal and respiratory illness in elementary school students: a randomized, controlled trial of an infection-control intervention. Pediatrics. 2008 Jun; 121(6):e1555-62. View abstract
  82. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol. 2008 May; 43(5):463-71. View abstract
  83. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics. 2008 Feb; 121(2):229-34. View abstract
  84. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008 Jan; 121(1):e15-23. View abstract
  85. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr. 2008 Feb; 152(2):225-31. View abstract
  86. Quality of health care for children: role of health and chronic illness in inpatient care experiences. Arch Pediatr Adolesc Med. 2007 Sep; 161(9):828-34. View abstract
  87. Adverse drug events in pediatric outpatients. Ambul Pediatr. 2007 Sep-Oct; 7(5):383-9. View abstract
  88. Impact of a hospitalist system on length of stay and cost for children with common conditions. Pediatrics. 2007 Aug; 120(2):267-74. View abstract
  89. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007 Jul; 75(7):3406-13. View abstract
  90. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7528-33. View abstract
  91. Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hosp Epidemiol. 2007 Mar; 28(3):261-4. View abstract
  92. Prospective surveillance for surgical site infection in St. Petersburg, Russian Federation. Infect Control Hosp Epidemiol. 2007 Mar; 28(3):319-25. View abstract
  93. Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial. Infect Control Hosp Epidemiol. 2007 Feb; 28(2):245-6; author reply 246-8. View abstract
  94. Hospital volumes for common pediatric specialty operations. Arch Pediatr Adolesc Med. 2007 Jan; 161(1):38-43. View abstract
  95. The association of television and video viewing with fast food intake by preschool-age children. Obesity (Silver Spring). 2006 Nov; 14(11):2034-41. View abstract
  96. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006 Oct; 118(4):1332-40. View abstract
  97. Incorporating vaccine-preventable disease surveillance into the National Health Information Network: leveraging children's hospitals. Pediatrics. 2006 Oct; 118(4):1431-8. View abstract
  98. System failure versus personal accountability--the case for clean hands. N Engl J Med. 2006 Jul 13; 355(2):121-3. View abstract
  99. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics. 2006 Jun; 117(6):e1170-8. View abstract
  100. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 2006 May; 74(5):2742-50. View abstract
  101. Impact of patient-centered decision support on quality of asthma care in the emergency department. Pediatrics. 2006 Jan; 117(1):e33-42. View abstract
  102. Patient misidentification in the neonatal intensive care unit: quantification of risk. Pediatrics. 2006 Jan; 117(1):e43-7. View abstract
  103. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatr Infect Dis J. 2005 Dec; 24(12):1053-8. View abstract
  104. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006 Feb 15; 173(4):421-5. View abstract
  105. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine. J Infect Dis. 2005 Dec 01; 192(11):2012-9. View abstract
  106. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun. 2005 Oct; 73(10):6868-76. View abstract
  107. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005 Oct; 73(10):6752-62. View abstract
  108. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005 Sep; 24(9):766-73. View abstract
  109. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics. 2005 Sep; 116(3):587-94. View abstract
  110. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005 Sep; 116(3):e408-13. View abstract
  111. Preventable adverse events in infants hospitalized with bronchiolitis. Pediatrics. 2005 Sep; 116(3):603-8. View abstract
  112. Real time patient safety audits: improving safety every day. Qual Saf Health Care. 2005 Aug; 14(4):284-9. View abstract
  113. Watchful waiting for acute otitis media: are parents and physicians ready? Pediatrics. 2005 Jun; 115(6):1466-73. View abstract
  114. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2005 Jun; 49(6):2467-73. View abstract
  115. Identification of central venous catheter-related infections in infants and children. Pediatr Crit Care Med. 2005 May; 6(3 Suppl):S19-24. View abstract
  116. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin Infect Dis. 2005 Jun 01; 40(11):1657-64. View abstract
  117. Medical errors detected and corrected by a pediatric infectious diseases consultation service. Infect Control Hosp Epidemiol. 2005 Apr; 26(4):417-20. View abstract
  118. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics. 2005 Apr; 115(4):852-60. View abstract
  119. Hospital-acquired neonatal infections in developing countries. Lancet. 2005 Mar 26-Apr 1; 365(9465):1175-88. View abstract
  120. Parents as partners in obtaining the medication history. J Am Med Inform Assoc. 2005 May-Jun; 12(3):299-305. View abstract
  121. Feasibility of leveraging electronic data from pediatric hospitals for national surveillance: a survey of chief information officers. AMIA Annu Symp Proc. 2005; 954. View abstract
  122. Controlling meticillin-resistant Staphylococcus aureus, aka "Superbug". Lancet. 2005 Jan 22-28; 365(9456):273-5. View abstract
  123. Evaluating vancomycin use at a pediatric hospital: new approaches and insights. Infect Control Hosp Epidemiol. 2005 Jan; 26(1):47-55. View abstract
  124. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol. 2004 Dec; 25(12):1083-9. View abstract
  125. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed. 2004 Nov; 89(6):F472-3. View abstract
  126. The asthma kiosk: a patient-centered technology for collaborative decision support in the emergency department. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):458-67. View abstract
  127. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics. 2004 Jun; 113(6):1609-18. View abstract
  128. Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis. 2004 May 15; 38(10):1383-90. View abstract
  129. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol. 2004 Apr; 186(8):2449-56. View abstract
  130. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 2004 Feb 17; 22(7):872-9. View abstract
  131. Administrative databases provide inaccurate data for surveillance of long-term central venous catheter-associated infections. Infect Control Hosp Epidemiol. 2003 Dec; 24(12):946-9. View abstract
  132. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003 Oct; 112(4):862-9. View abstract
  133. Notifying emergency department patients of negative test results: pitfalls of passive communication. Pediatr Emerg Care. 2003 Aug; 19(4):226-30. View abstract
  134. A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip. J Bone Joint Surg Am. 2003 Jun; 85(6):994-9. View abstract
  135. Evaluation and development of potentially better practices to prevent neonatal nosocomial bacteremia. Pediatrics. 2003 Apr; 111(4 Pt 2):e504-18. View abstract
  136. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003 Apr; 111(4 Pt 1):722-9. View abstract
  137. Use of an alcohol-based hand rub and quality improvement interventions to improve hand hygiene in a Russian neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003 Mar; 24(3):172-9. View abstract
  138. Senior resident autonomy in a pediatric hospitalist system. Arch Pediatr Adolesc Med. 2003 Feb; 157(2):206-7. View abstract
  139. Misconceptions about colds and predictors of health service utilization. Pediatrics. 2003 Feb; 111(2):231-6. View abstract
  140. Binary cumulative sums and moving averages in nosocomial infection cluster detection. Emerg Infect Dis. 2002 Dec; 8(12):1426-32. View abstract
  141. Impact of a health maintenance organization hospitalist system in academic pediatrics. Pediatrics. 2002 Oct; 110(4):720-8. View abstract
  142. Time to tackle the tough issues in patient safety. Pediatrics. 2002 Oct; 110(4):823-6. View abstract
  143. Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med. 2002 Sep; 156(9):877-83. View abstract
  144. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun. 2002 Aug; 70(8):4433-40. View abstract
  145. Blood-borne pathogens and nosocomial infections. J Allergy Clin Immunol. 2002 Aug; 110(2 Suppl):S21-6. View abstract
  146. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J. 2002 Aug; 21(8):715-23. View abstract
  147. Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr Infect Dis J. 2002 Jun; 21(6):489-95. View abstract
  148. Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils. Transplantation. 2002 May 15; 73(9):1522-6. View abstract
  149. Pediatric hospitalists: what do we know, and where do we go from here? Ambul Pediatr. 2001 Nov-Dec; 1(6):340-5. View abstract
  150. Computerized pharmacy databases as source of data on antimicrobial prescriptions in children's hospitals. Am J Health Syst Pharm. 2001 Nov 01; 58(21):2069-71. View abstract
  151. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis. 2001 Nov; 1(4):251-61. View abstract
  152. Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods. Arch Intern Med. 2001 Oct 22; 161(19):2357-65. View abstract
  153. Compliance with hand hygiene practice in pediatric intensive care. Pediatr Crit Care Med. 2001 Oct; 2(4):311-4. View abstract
  154. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001 Jun; 107(6):1431-6. View abstract
  155. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet. 2001 May; 73(2):141-5. View abstract
  156. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001 Apr 25; 285(16):2114-20. View abstract
  157. Reality check: should we use vancomycin for the prophylaxis of intravascular catheter-associated infections? Infect Control Hosp Epidemiol. 2001 Mar; 22(3):176-9. View abstract
  158. Market forces and organizational evolution at freestanding children's hospitals in the United States. Ambul Pediatr. 2001 Mar-Apr; 1(2):117-21. View abstract
  159. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis. 2001 Mar-Apr; 7(2):249-53. View abstract
  160. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J. 2000 Oct; 19(10 Suppl):S97-102. View abstract
  161. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 2000 Sep 29; 83(1-2):37-44. View abstract
  162. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Infect Immun. 2000 Sep; 68(9):5120-5. View abstract
  163. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000 Aug; 68(8):4631-6. View abstract
  164. Reducing medical error through systems improvement: the management of febrile infants. Pediatrics. 2000 Jun; 105(6):1330-2. View abstract
  165. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J. 2000 Jan; 19(1):56-65. View abstract
  166. Risk-adjusted infection rates in surgery: a model for outcome measurement in hospitals developing new quality improvement programmes. J Hosp Infect. 2000 Jan; 44(1):43-52. View abstract
  167. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics. 1999 Dec; 104(6):1327-33. View abstract
  168. Quality of care at a children's hospital: the parent's perspective. Arch Pediatr Adolesc Med. 1999 Nov; 153(11):1123-9. View abstract
  169. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999 May 28; 284(5419):1523-7. View abstract
  170. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr. 1999 Apr; 134(4):413-21. View abstract
  171. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun. 1999 Mar; 67(3):1213-9. View abstract
  172. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999; 50:223-36. View abstract
  173. Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics. 1998 Oct; 102(4 Pt 1):893-9. View abstract
  174. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 1998 Oct; 66(10):4711-20. View abstract
  175. Prevention of occupationally acquired infections among heath-care workers. Pediatr Rev. 1998 Jul; 19(7):219-30; quiz 231. View abstract
  176. Hospital infection prevention and control: a model for improving the quality of hospital care in low- and middle-income countries. Infect Control Hosp Epidemiol. 1998 Feb; 19(2):125-35. View abstract
  177. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998 Jan; 17(1):10-7. View abstract
  178. Social disparities in the use of diagnostic tests for children with gastroenteritis. Int J Qual Health Care. 1997 Dec; 9(6):419-25. View abstract
  179. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis. 1997 Jan; 24 Suppl 1:S139-45. View abstract
  180. Resistance movement: the antibiotic crisis in hospitals. Health Syst Rev. 1997 Jan-Feb; 30(1):20-4. View abstract
  181. When normal flora turn nasty. Pediatr Infect Dis J. 1996 Oct; 15(10):845-7. View abstract
  182. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA. 1996 Jan 17; 275(3):234-40. View abstract
  183. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 1995 Nov 01; 92(9):2715-22. View abstract
  184. A clinical pathway for pelvic inflammatory disease for use on an inpatient service. Clin Perform Qual Health Care. 1995 Oct-Dec; 3(4):185-96. View abstract
  185. Promoting collaboration between hospital epidemiology and QI. Interview by Steven Berman. Jt Comm J Qual Improv. 1995 Sep; 21(9):493-500. View abstract
  186. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995 Jun; 14(6):510-6. View abstract
  187. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr Clin North Am. 1995 Jun; 42(3):703-16. View abstract
  188. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995 Mar; 95(3):389-94. View abstract
  189. Neonatal herpes simplex virus infection presenting as fulminant liver failure. Pediatr Infect Dis J. 1995 Mar; 14(3):242-4. View abstract
  190. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 1995 Feb; 95(2):225-30. View abstract
  191. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis. 1995 Jan; 171(1):220-4. View abstract
  192. CRIB and SNAP. Lancet. 1994 Jul 09; 344(8915):124-5. View abstract
  193. Estimating neonatal mortality risk: an analysis of clinicians' judgments. Pediatrics. 1994 Jun; 93(6 Pt 1):945-50. View abstract
  194. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis. 1994 May; 169(5):1042-9. View abstract
  195. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis. 1994 Mar; 169(3):526-31. View abstract
  196. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis. 1993 Nov; 168(5):1211-8. View abstract
  197. The immunization status of children with spina bifida. Am J Dis Child. 1993 Aug; 147(8):849-53. View abstract
  198. Computed tomography imaging in children with head trauma: utilization and appropriateness from a quality improvement perspective. Infect Control Hosp Epidemiol. 1993 Aug; 14(8):491-9. View abstract
  199. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics. 1993 May; 91(5):969-75. View abstract
  200. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev. 1993 Apr; 6(2):176-92. View abstract
  201. Hospital-based continuous quality improvement: a realistic appraisal. Clin Perform Qual Health Care. 1993 Apr-Jun; 1(2):69-80. View abstract
  202. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993 Mar; 91(3):617-23. View abstract
  203. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 Feb; 61(2):551-8. View abstract
  204. Vancomycin-resistant enterococcus faecium: headline news. Infect Control Hosp Epidemiol. 1992 Dec; 13(12):695-9. View abstract
  205. Variability in reprocessing policies and procedures for flexible fiberoptic endoscopes in Massachusetts hospitals. Am J Infect Control. 1992 Dec; 20(6):283-90. View abstract
  206. The articular manifestations of Paget's disease of bone. A case report. Clin Orthop Relat Res. 1992 Dec; (285):250-4. View abstract
  207. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics. 1992 Oct; 90(4):561-7. View abstract
  208. Transmission of infectious diseases in children. Pediatr Rev. 1992 Aug; 13(8):283-93. View abstract
  209. Hand-washing and nosocomial infections. N Engl J Med. 1992 Jul 09; 327(2):120-2. View abstract
  210. A service chief model for general pediatric inpatient care and residency training. Pediatrics. 1992 Apr; 89(4 Pt 1):601-7. View abstract
  211. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med. 1992 Mar; 92(3):257-61. View abstract
  212. Rapid detection of group A streptococci: comparative performance by nurses and laboratory technologists in pediatric satellite laboratories using three test kits. J Clin Microbiol. 1992 Jan; 30(1):138-42. View abstract
  213. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 1991 Dec; 84(6):2539-46. View abstract
  214. Contemporary challenges for hospital epidemiology. Am J Med. 1991 Sep 16; 91(3B):8S-15S. View abstract
  215. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Med. 1991 Sep 16; 91(3B):213S-220S. View abstract
  216. Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun. 1991 Sep; 59(9):3323-6. View abstract
  217. The role of barrier precautions in infection control. J Hosp Infect. 1991 Jun; 18 Suppl A:515-23. View abstract
  218. False resistance to imipenem with a microdilution susceptibility testing system. J Clin Microbiol. 1991 Apr; 29(4):827-9. View abstract
  219. Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1991 Feb; 35(2):272-6. View abstract
  220. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990 Dec 27; 323(26):1814-8. View abstract
  221. Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding. Am J Epidemiol. 1990 Dec; 132(6):1130-40. View abstract
  222. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990 Aug 02; 323(5):301-8. View abstract
  223. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 1990 Aug; 162(2):435-41. View abstract
  224. Coagulase-negative staphylococci: interplay of epidemiology and bench research. Am J Infect Control. 1990 Jun; 18(3):211-21. View abstract
  225. Enzymatically labelled nucleic acid (NA) probe assays for detection of Campylobacter spp. in human faecal specimens and in culture. Mol Cell Probes. 1990 Apr; 4(2):133-42. View abstract
  226. Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child. 1990 Mar; 144(3):324-9. View abstract
  227. Microbial challenge of a blood cell separator outside-seal bowl system. Transfusion. 1990 Feb; 30(2):146-9. View abstract
  228. Current issues in central venous catheter infection. Annu Rev Med. 1990; 41:169-76. View abstract
  229. Prevention and management of neonatal infections. Infect Dis Clin North Am. 1989 Dec; 3(4):779-813. View abstract
  230. AIDS: understanding the pathogenesis of HIV infection. Infect Control Hosp Epidemiol. 1989 Jun; 10(6):248-52. View abstract
  231. Heterologous protection against invasive Escherichia coli K1 disease in newborn rats by maternal immunization with purified mannose-sensitive pili. Infect Immun. 1989 May; 57(5):1568-72. View abstract
  232. Nosocomial viral infections: recent developments and new strategies. Eur J Clin Microbiol Infect Dis. 1989 Jan; 8(1):75-81. View abstract
  233. Methodologic issues in hospital epidemiology. IV. Risk ratios, confounding, effect modification, and the analysis of multiple variables. Rev Infect Dis. 1988 Nov-Dec; 10(6):1118-41. View abstract
  234. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother. 1988 Oct; 32(10):1528-32. View abstract
  235. Infection control in Latin America. Infect Control Hosp Epidemiol. 1988 Jul; 9(7):291-301. View abstract
  236. Performance of a solid phase enzyme immunoassay for detection of group A streptococci in a pediatric office laboratory as refereed by a hospital laboratory. Pediatr Infect Dis J. 1988 Jun; 7(6):393-8. View abstract
  237. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr. 1988 Apr; 112(4):547-54. View abstract
  238. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988 Apr; 157(4):713-22. View abstract
  239. Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol. 1988 Apr; 26(4):713-8. View abstract
  240. Effect of preoperative shampoos on resident scalp flora. Todays OR Nurse. 1988 Mar; 10(3):15-21. View abstract
  241. Group B streptococcal infections of the central nervous system in infants with myelomeningocele. Surg Neurol. 1988 Mar; 29(3):237-42. View abstract
  242. The bacterial flora of neonates in intensive care-monitoring and manipulation. J Hosp Infect. 1988 Feb; 11 Suppl A:340-51. View abstract
  243. Effect of preoperative shampoos with chlorhexidine or iodophor on emergence of resident scalp flora in neurosurgery. Infect Control. 1988 Jan; 9(1):8-12. View abstract
  244. Effect of preoperative shampoos with chlorhexidine or iodophor on emergence of resident scalp flora in neurosurgery. Infect Control Hosp Epidemiol. 1988 Jan; 9(1):8-12. View abstract
  245. Impact of rapid antigen tests for group A streptococcal pharyngitis on physician use of antibiotics and throat cultures. Pediatr Infect Dis J. 1987 Dec; 6(12):1095-102. View abstract
  246. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA. 1987 Nov 13; 258(18):2548-52. View abstract
  247. Confounding and the analysis of multiple variables in hospital epidemiology. Infect Control. 1987 Nov; 8(11):465-73. View abstract
  248. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med. 1987 Aug 06; 317(6):329-34. View abstract
  249. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media. Diagn Microbiol Infect Dis. 1986 Nov; 5(4):299-305. View abstract
  250. Nosocomial infection control in the United States of America. J Hosp Infect. 1986 Sep; 8(2):116-28. View abstract
  251. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986 May; 108(5 Pt 2):806-12. View abstract
  252. Strategies for preventing neonatal group B streptococcal disease. Infect Control. 1986 Feb; 7(2 Suppl):137-9, 143. View abstract
  253. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis. Clin Pharm. 1985 Nov-Dec; 4(6):664-9. View abstract
  254. Risk of illness after exposure to a pediatric office. N Engl J Med. 1985 Aug 15; 313(7):425-8. View abstract
  255. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis. Rev Infect Dis. 1985 Jul-Aug; 7 Suppl 3:S482-9. View abstract
  256. Comparison of a new, rapid enzyme-linked immunosorbent assay with latex particle agglutination for the detection of Haemophilus influenzae type b infections. J Clin Microbiol. 1985 May; 21(5):711-4. View abstract
  257. Purification and characterization of Haemophilus influenzae pili, and their structural and serological relatedness to Escherichia coli P and mannose-sensitive pili. J Exp Med. 1985 Jan 01; 161(1):145-59. View abstract
  258. Intravenous fluid contamination, Aegean-style. Infect Control. 1984 Oct; 5(10):469-70. View abstract
  259. Pilus-mediated adherence of Escherichia coli K1 to human oral epithelial cells. Infect Immun. 1984 Jul; 45(1):299-301. View abstract
  260. Empyema in children: clinical course and long-term follow-up. Pediatrics. 1984 May; 73(5):587-93. View abstract
  261. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b. Antimicrob Agents Chemother. 1983 Nov; 24(5):658-62. View abstract
  262. The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis. 1983 Sep; 148(3):395-405. View abstract
  263. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b. Rev Infect Dis. 1983 Jul-Aug; 5 Suppl 3:S549-55. View abstract
  264. In vitro activity of penicillin and rifampin against group B streptococci. Rev Infect Dis. 1983 Jul-Aug; 5 Suppl 3:S586-92. View abstract
  265. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. J Antimicrob Chemother. 1983 May; 11 Suppl B:195-203. View abstract
  266. Nosocomial infection and death in a neonatal intensive care unit. J Infect Dis. 1983 Apr; 147(4):635-41. View abstract
  267. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. Antimicrob Agents Chemother. 1983 Apr; 23(4):571-6. View abstract
  268. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. J Infect Dis. 1983 Mar; 147(3):559-67. View abstract
  269. Comparison of virulence and colonizing capacity of Escherichia coli K1 and non-K1 strains in neonatal rats. Infect Immun. 1982 Aug; 37(2):830-2. View abstract
  270. Moxalactam pharmacokinetics in children. Antimicrob Agents Chemother. 1982 Jul; 22(1):47-50. View abstract
  271. Nosocomial infections in a neonatal intensive care unit. J Infect Dis. 1981 Nov; 144(5):449-59. View abstract
  272. Improved antibiotic usage following introduction of a novel prescription system. JAMA. 1981 Oct 16; 246(16):1796-800. View abstract
  273. Mucoid Escherichia coli in cystic fibrosis. N Engl J Med. 1981 Jun 11; 304(24):1445-9. View abstract
  274. Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med. 1981 Mar; 94(3):346-9. View abstract
  275. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr. 1981 Mar; 98(3):485-91. View abstract
  276. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med. 1981 Mar; 70(3):702-6. View abstract
  277. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb; 19(2):294-7. View abstract
  278. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol. 1980 Jun; 11(6):552-7. View abstract
  279. Haemophilus influenzae type B meningitis: a contagious disease of children. Br Med J. 1980 Mar 29; 280(6218):899-901. View abstract
  280. Airborne transmission of chickenpox in a hospital. N Engl J Med. 1980 Feb 21; 302(8):450-3. View abstract
  281. Salmonella bacteremia in the first year of life. J Pediatr. 1980 Jan; 96(1):57-9. View abstract
  282. Guidelines for infection control in intravenous therapy. Lamp. 1979 Mar; 36(2):4-6. View abstract
  283. Effect of ampicillin and chloramphenicol alone and in combination on ampicillin-susceptible and -resistant Haemophilus influenzae type B. Antimicrob Agents Chemother. 1979 Mar; 15(3):415-9. View abstract
  284. Evaluation of blood culture procedures in a pediatric hospital. J Clin Microbiol. 1979 Jan; 9(1):88-92. View abstract
  285. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. Am J Epidemiol. 1978 Sep; 108(3):207-13. View abstract
  286. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr. 1978 Aug; 93(2):288-93. View abstract
  287. Quantitative blood cultures in childhood bacteremia. J Pediatr. 1978 May; 92(5):778-80. View abstract
  288. Unreliability of fever and leukocytosis in the diagnosis of infection after cardiac valve surgery. J Thorac Cardiovasc Surg. 1978 Jan; 75(1):87-90. View abstract
  289. Correlation of netilmicin agar dilution and disk diffusion susceptibilities. Antimicrob Agents Chemother. 1977 Aug; 12(2):288-9. View abstract
  290. Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg. 1977 Mar; 73(3):470-9. View abstract
  291. False-positive blood cultures. Association with nonsterile blood collection tubes. JAMA. 1976 Nov 01; 236(18):2073-5. View abstract
  292. Editorial: Nosocomial infection--a hazard of newborn intensive care. N Engl J Med. 1976 Jun 10; 294(24):1342-3. View abstract
  293. An outbreak of Shigella sonnei gastroenteritis on Colorado River raft trips. Am J Epidemiol. 1974 Sep; 100(3):186-96. View abstract
  294. Letter: Contamination of fluid for parenteral nutrition. N Engl J Med. 1974 Jun 20; 290(25):1437-8. View abstract
  295. Infection control in total parenteral nutrition. JAMA. 1973 Mar 19; 223(12):1360-4. View abstract
  296. Staphylococcal disease related to hospital nursery bathing practices. A nationwide epidemiologic investigation. Pediatrics. 1973 Feb; 51(2):418-29. View abstract